| Cash flow (USD) | FY 2025 ended Dec 28, 2025 | FY 2024 ended Dec 29, 2024 | FY 2023 ended Dec 31, 2023 | FY 2022 ended Jan 1, 2023 | FY 2021 ended Jan 2, 2022 | FY 2020 ended Jan 3, 2021 |
|---|---|---|---|---|---|---|
| Net income | 26.80B | 14.07B | 35.15B | 17.94B | 20.88B | 14.71B |
| Depreciation and amortization | 7.50B | 7.34B | 7.49B | 6.97B | 7.39B | 7.23B |
| Stock-based compensation | 1.35B | 1.18B | 1.16B | 1.14B | 1.14B | 1.00B |
| Cash from operations | 24.53B | 24.27B | 22.79B | 21.19B | 23.41B | 23.54B |
| Capital expenditure | -4.83B | -4.42B | -4.54B | -4.01B | -3.65B | -3.35B |
| Free cash flow | 19.70B | 19.84B | 18.25B | 17.18B | 19.76B | 20.19B |
| Acquisitions | -17.50B | -15.15B | 0 | -17.65B | -60.00M | -7.32B |
| Cash from investing | -23.59B | -18.60B | 878.00M | -12.37B | -8.68B | -20.82B |
| Share buybacks | -5.95B | -2.43B | -5.05B | -6.04B | -3.46B | -3.22B |
| Net debt issued | 7.38B | 5.21B | -1.55B | -2.13B | -1.80B | 6.37B |
| Cash from financing | -5.54B | -3.13B | -15.82B | -8.87B | -14.05B | -6.12B |
| Net change in cash | -4.40B | 2.25B | 7.73B | -360.00M | 502.00M | -3.32B |
From Johnson & Johnson's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read cash flow or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.